Publications by authors named "Amy Mallorie"
Article Synopsis
- ASCEND PLUS is a large clinical trial in the UK aimed at preventing cardiovascular events in individuals with type 2 diabetes by using oral semaglutide, emphasizing a decentralized recruitment and follow-up method.
- The trial significantly involved patient and public input (PPIE) throughout its design and implementation, utilizing focus groups and an advisory group to ensure diverse perspectives were included.
- Results from the PPIE activities influenced key trial features, such as providing participants with flexible options for the screening process and creating user-friendly information materials, which were refined based on feedback from the advisory group.
Background: Ascertainment of heart failure (HF) hospitalizations in cardiovascular trials is costly and complex, involving processes that could be streamlined by using routinely collected healthcare data (RCD). The utility of coded RCD for HF outcome ascertainment in randomized trials requires assessment. We systematically reviewed studies assessing RCD-based HF outcome ascertainment against "gold standard" (GS) methods to study the feasibility of using such methods in clinical trials.
View Article and Find Full Text PDFObjectives: The risk of recurrent venous thromboembolic disease and the management of patients with isolated subsegmental pulmonary embolism (SSPE) remain unclear. We sought to assess the long-term clinical outcome of patients with isolated SSPE demonstrated by isolated subsegmental mismatch found on ventilation/perfusion (V/Q) scans.
Patients And Methods: We performed a retrospective observational study of 1300 consecutive patients with suspected pulmonary embolism who underwent index V/Q single-photon emission computed tomography between 2012 and 2013.
Objectives: Lymph node involvement in non-small-cell lung cancer (NSCLC) is a major factor in determining management and prognosis. We aimed to evaluate the accuracy of fluorine-18-fluorodeoxyglucose-PET/computed tomography (CT) for the assessment of nodal involvement in patients with NSCLC.
Patients And Methods: In this retrospective study, we included 61 patients with suspected or confirmed resectable NSCLC over a 2-year period from April 2013 to April 2015.
Objective: Myocardial fibrosis identified by late gadolinium enhancement (LGE) cardiovascular magnetic resonance (CMR) in patients with hypertrophic cardiomyopathy (HCM) is associated with adverse cardiovascular events, but its value as an independent risk factor for sudden cardiac death (SCD) is unknown. We investigated the role of LGE-CMR in the risk stratification of HCM.
Methods: We conducted a prospective cohort study in a tertiary referral centre.